Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 1339; doi:10.1093/annonc/mdl326
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

David J. Kerr

KISS: the 2006 Annals of Oncology prizes
Ann Oncol 17: 1341-1342; doi:10.1093/annonc/mdl324
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S Faivre and E Raymond

Management of neuromuscular dose limiting toxicity at the early stage of drug development
Ann Oncol 17: 1343-1346; doi:10.1093/annonc/mdl325
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

I Chau and D Cunningham

Adjuvant therapy in colon cancer—what, when and how?
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 1347-1359; doi:10.1093/annonc/mdl029
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

R Sawhney, D Bourgeois, and UB Chaudhary

Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 1360-1369; doi:10.1093/annonc/mdl008
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

original articles:

phase I and pharmacokinetics:

JA Maroun, K Belanger, L Seymour, S Matthews, J Roach, J Dionne, D Soulieres, D Stewart, R Goel, D Charpentier, G Goss, E Tomiak, J Yau, J Jimeno, and G Chiritescu

Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115
Ann Oncol 17: 1371-1378; doi:10.1093/annonc/mdl165
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

R Leonard, J O'Shaughnessy, S Vukelja, V Gorbounova, CA Chan-Navarro, D Maraninchi, N Barak-Wigler, JJ McKendrick, WG Harker, AS Bexon, and C Twelves

Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
Ann Oncol 17: 1379-1385; doi:10.1093/annonc/mdl134
[Abstract] [Full Text] [PDF] [Request Permissions]

ME Cazzaniga, G Mustacchi, P Pronzato, A De Matteis, F Di Costanzo, and I Floriani On behalf of the NORA Study Group

Adjuvant systemic treatment of early breast cancer: the NORA study
Annals of Oncology Advance Access published on June 21, 2006
Ann Oncol 17: 1386-1392; doi:10.1093/annonc/mdl132
[Abstract] [Full Text] [PDF] [Request Permissions]

SIK Semple, RT Staff, SD Heys, TW Redpath, AE Welch, TS Ahearn, AW Hutcheon, and FJ Gilbert

Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration
Annals of Oncology Advance Access published on June 20, 2006
Ann Oncol 17: 1393-1398; doi:10.1093/annonc/mdl136
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

BJ Giantonio, DE Levy, PJ O'Dwyer, NJ Meropol, PJ Catalano, and AB Benson, III

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 17: 1399-1403; doi:10.1093/annonc/mdl161
[Abstract] [Full Text] [PDF] [Request Permissions]

B Brenner, MA Shah, MS Karpeh, M Gonen, MF Brennan, DG Coit, DS Klimstra, LH Tang, and DP Kelsen

A phase II trial of neoadjuvant cisplatin–fluorouracil followed by postoperative intraperitoneal floxuridine–leucovorin in patients with locally advanced gastric cancer
Annals of Oncology Advance Access published on June 20, 2006
Ann Oncol 17: 1404-1411; doi:10.1093/annonc/mdl133
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

AB Cortot, L Gerinière, G Robinet, J-L Breton, R Corre, L Falchero, H Berard, C Gimenez, J-M Chavaillon, M Perol, P Bombaron, C Mercier, and P-J Souquet

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study
Annals of Oncology Advance Access published on June 21, 2006
Ann Oncol 17: 1412-1417; doi:10.1093/annonc/mdl146
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

BS Kahl, WL Longo, JC Eickhoff, J Zehnder, C Jones, J Blank, T McFarland, W Bottner, H Rezazedeh, J Werndli, and HH Bailey

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1418-1423; doi:10.1093/annonc/mdl127
[Abstract] [Full Text] [PDF] [Request Permissions]

F Cabanillas, I Liboy, O Pavia, and E Rivera

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication
Ann Oncol 17: 1424-1427; doi:10.1093/annonc/mdl141
[Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]

UKH Haukvik, I Dieset, T Bjøro, H Holte, and SD Fosså

Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
Annals of Oncology Advance Access published on July 10, 2006
Ann Oncol 17: 1428-1433; doi:10.1093/annonc/mdl149
[Abstract] [Full Text] [PDF] [Request Permissions]

C Visco, L Arcaini, E Brusamolino, S Burcheri, A Ambrosetti, M Merli, E Bonoldi, M Chilosi, A Viglio, M Lazzarino, G Pizzolo, and F Rodeghiero

Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1434-1440; doi:10.1093/annonc/mdl131
[Abstract] [Full Text] [PDF] [Request Permissions]

supportive care:

MS Aapro, SM Grunberg, GM Manikhas, G Olivares, T Suarez, SA Tjulandin, LF Bertoli, F Yunus, B Morrica, F Lordick, and A Macciocchi

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1441-1449; doi:10.1093/annonc/mdl137
[Abstract] [Full Text] [PDF] [Request Permissions]

oncology practice:

A Liénard, I Merckaert, Y Libert, N Delvaux, S Marchal, J Boniver, A-M Etienne, J Klastersky, C Reynaert, P Scalliet, J-L Slachmuylder, and D Razavi

Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians
Annals of Oncology Advance Access published on June 26, 2006
Ann Oncol 17: 1450-1458; doi:10.1093/annonc/mdl142
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

W Garavello, G Randi, C Bosetti, L Dal Maso, E Negri, L Barzan, S Franceschi, and C La Vecchia

Body size and laryngeal cancer risk
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 17: 1459-1463; doi:10.1093/annonc/mdl166
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

K Altundag, CD Moussallem, and MZ Baptista

Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy
Annals of Oncology Advance Access published on April 20, 2006
Ann Oncol 17: 1465; doi:10.1093/annonc/mdl052
[Extract] [Full Text] [PDF] [Request Permissions]

A Scherwath

Reply to ‘Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy’ by K. Altundag et al. (Ann Oncol 2006; 17: 1465)
Annals of Oncology Advance Access published on April 20, 2006
Ann Oncol 17: 1465-1466; doi:10.1093/annonc/mdl051
[Extract] [Full Text] [PDF] [Request Permissions]

C Moro, R Taino, M Mandalà, and R Labianca

Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy
Annals of Oncology Advance Access published on April 26, 2006
Ann Oncol 17: 1466-1467; doi:10.1093/annonc/mdl059
[Extract] [Full Text] [PDF] [Request Permissions]

A Eroglu, S Gulec, C Kurtman, R Cam, and N Akar

Vascular endothelial growth factor 936 C/T polymorphism in cancer patients
Annals of Oncology Advance Access published on April 6, 2006
Ann Oncol 17: 1467-1468; doi:10.1093/annonc/mdl075
[Extract] [Full Text] [PDF] [Request Permissions]

U Wedding, B Röhrig, K Hoeffken, and L Pientka

Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy
Annals of Oncology Advance Access published on April 19, 2006
Ann Oncol 17: 1468-1469; doi:10.1093/annonc/mdl076
[Extract] [Full Text] [PDF] [Request Permissions]

J Cassidy

In response to: ‘On prejudice and facts and choices’, an editorial by Köhne and Folprecht
Annals of Oncology Advance Access published on May 9, 2006
Ann Oncol 17: 1469-1471; doi:10.1093/annonc/mdl082
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.